Long-Term Resveratrol Supplementation as a Secondary Prophylaxis for Stroke
Table 2
Effect of resveratrol on blood pressure.
Evaluation
BP (mmHg)
Systolic BP
ES
Diastolic BP
ES
Resveratrol 100 mg group
Initial
148.02 ± 15.28
—
88.29 ± 10.73
—
At 6 months
143.12 ± 15.16
0.32
85.89 ± 10.22
0.22
At 12 months
139.85 ± 14.82
0.22
84.27 ± 10.18
0.16
Resveratrol 200 mg group
Initial
149.21 ± 15.13
—
88.47 ± 11.11
—
At 6 months
142.02 ± 15.27∗
0.48
85.91 ± 11.02
0.23
At 12 months
139.35 ± 14.81
0.17
84.10 ± 10.78
0.16
Control group
Initial
148.42 ± 15.22
—
87.61 ± 11.25
—
At 6 months
146.10 ± 15.17
0.16
86.39 ± 11.32
0.11
At 12 months
145.32 ± 15.25
0.05
85.67 ± 11.11
0.06
Values are represented as mean ± SD ( patients in the resveratrol 100 mg group; patients in the resveratrol 200 mg group; and patients in the control group); versus initial value; <0.05 versus control group value.